BioWorld Asia

Oct. 17, 2007

Look At Health Care Through Different Lens, P&G Advises

LONDON - Proctor and Gamble (P&G) is applying its expertise as a consumer products giant to get a patient's eye view of disease and use the insights to inform development programs with biotech partners. (BioWorld International) Read More

EuropaBio Takes Its Message To The Top

Genetic Screening For Bowel Cancer Risk Closer To Reality

Victoria Sets A Lofty Goal For Advancing Its Biotech

Cellectis and Servier Enter Cell Engineering Alliance

Other News To Note

Nobel Laureate's Interests Are As Broad As His Technology

Deals To M&As: The Culture Of False-Flagging, Shape-Shifting

Orexo Acquires A Pipeline In $133M Deal for Biolipox

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...